China's exponential rise and America's relative decline have led to a transition of power in contemporary Asia. The US pivot towards Asia is the most evident manifestation of such a transition, and Indian foreign policy shows signs of a hedging strategy, with attempts to strengthen ties with both China and the US.

Exposes the invisible ways in which white Christian privilege disadvantages racial and religious minorities in America The United States is recognized as the most religiously diverse country in the world, and yet its laws and customs, which many have come to see as normal features of American life, actually keep the Constitutional ideal of "religious freedom for all" from becoming a reality. Christian beliefs, norms, and practices infuse our society; they are embedded in our institutions, creating the structures and expectations that define the idea of "Americanness." Religious minorities still struggle for recognition and for the opportunity to be treated as fully and equally legitimate members of American society. From the courtroom to the classroom, their scriptures and practices are viewed with suspicion, and bias embedded in centuries of Supreme Court rulings create structural disadvantages that endure today. In White Christian Privilege, Khyati Y. Joshi traces Christianity's influence on the American experiment from before the founding of the Republic to the social movements of today. Mapping the way through centuries of slavery, westward expansion, immigration, and citizenship laws, she also reveals the ways Christian privilege in the United States has always been entangled with notions of White supremacy. Through the voices of Christians and religious minorities, Joshi explores how Christian privilege and White racial norms affect the lives of all Americans, often in subtle ways that society overlooks. By shining a light on the inequalities these privileges create, Joshi points the way forward, urging readers to help remake America as a diverse democracy with a commitment to true religious freedom.

Exposes the invisible ways in which white Christian privilege disadvantages racial and religious minorities in America The United States is recognized as the most religiously diverse country in the world, and yet its laws and customs, which many have come to see as normal features of American life, actually keep the Constitutional ideal of "religious freedom for all" from becoming a reality. Christian beliefs, norms, and practices infuse our society; they are embedded in our institutions, creating the structures and expectations that define the idea of "Americanness." Religious minorities still struggle for recognition and for the opportunity to be treated as fully and equally legitimate members of American society. From the courtroom to the classroom, their scriptures and practices are viewed with suspicion, and bias embedded in centuries of Supreme Court rulings create structural disadvantages that endure today. In White Christian Privilege, Khyati Y. Joshi traces Christianity's influence on the American experiment from before the founding of the Republic to the social movements of today. Mapping the way through centuries of slavery, westward expansion, immigration, and citizenship laws, she also reveals the ways Christian privilege in the United States has always been entangled with notions of White supremacy. Through the voices of Christians and religious minorities, Joshi explores how Christian privilege and White racial norms affect the lives of all Americans, often in subtle ways that society overlooks. By shining a light on the inequalities these privileges create, Joshi points the way forward, urging readers to help remake America as a diverse democracy with a commitment to true religious freedom.

In Envisioning Religion, Race, and Asian Americans, David K. Yoo and Khyati Y. Joshi assemble a wide-ranging and important collection of essays documenting the intersections of race and religion and Asian American communities - a combination so often missing both in the scholarly literature and in public discourse. Issues of religion and race/ethnicity undergird current national debates around immigration, racial profiling, and democratic freedoms, but these issues, as the contributors document, are longstanding ones in the United States. The essays feature dimensions of traditions such as Islam, Hinduism, and Sikhism, as well as how religion engages with topics that include religious affiliation (or lack thereof), the legacy of the Vietnam War, and popular culture. The contributors also address the role of survey data, pedagogy, methodology, and literature that is richly complementary and necessary for understanding the scope and range of the subject of Asian American religions. These essays attest to the vibrancy and diversity of Asian American religions, while at the same time situating these conversations in a scholarly lineage and discourse. This collection will certainly serve as an invaluable resource for scholars, students, and general readers with interests in Asian American religions, ethnic and Asian American studies, religious studies, American studies, and related fields that focus on immigration and race.

Road traffic injuries account for 2.1% of global mortality. The developing countries bear a large share of burden and account for about 85% of the deaths as a result of road traffic crashes. 2] India accounts for about 10% of road accident fatalities worldwide. 3] Road accident contributed 30.2% to all kind of natural and unnatural accidental deaths during 2005 4]. According to the Institute of Road Traffic Education (2006) New Delhi, out of the estimated 1.4 million serious road accidents/ collisions occurring annually in India, hardly 0.4 million are recorded. 5] This indicates that the surveillance system for vehicular accidents is not well established in India. Epidemiological data on road traffic accidents in India have been reported but there is no proper correlation with head injury. The study correlating head injury with road traffic accidents in Delhi was done in 1979 since then there have been significant social and demographic changes including changes in life style, population and number of vehicles. Continuous growth in number of motor vehicles, increase in population and poor access to health care are some of the important factors in fatalities.

Given the well-defined loss of a specific type of neurons (dopaminergic neurons) in a well defined region of the brain (S. nigra), the concept of cell replacement therapy in PD has emerged already in the early 1980s.Replacing diseased cells with healthy cells, called cell therapy, is similar to the process of organ transplantation only the treatment consists of transplanting cells instead of organs. Some conditions or injuries can be treated through transplantation of entire healthy organs, but there is an acute shortage of donors. Stem cells can serve as an alternate and renewable source for specialized cells.These unique characteristics make stem cells very promising for supplying cells to treat debilitating diseases like Alzheimer's disease, cancer, Parkinson's disease, type-1 diabetes, spinal cord injury, stroke, burns, heart disease, osteoarthritis and rheumatoid arthritis. Today, donated organs and tissues are often used to replace those that are diseased or destroyed. Unfortunately, the number of people needing transplants far exceeds the number of organs available.

Liposomes as well as formulations based on drug-lipid complexes have been extensively investigated for the delivery of a wide range of pharmaceutical compounds. Commercial licensing of liposomal dispersions for parenteral and topical use in humans has been fairly recent and has occurred as a result of interdisciplinary scientific advances in surface chemistry, membrane biophysics, and molecular pharmacology. These developments were supported by pioneering contributions from scientists in the fields of molecular pharmaceutics, drug delivery, and chemical engineering. Thus, since their original simplistic use as vesicular models for studying membrane properties and transport, liposomal systems have evolved into complex yet elegant assemblies for drug delivery. Liposomes are now being developed with specific therapeutic roles for tissue and cellular targeting and have been skillfully manipulated to achieve desired clinical outcomes by altering in vivo drug biodistribution and disposition. Liposomes are microscopic vesicles composed of one or more lipid bilayers arranged in concentric fashion enclosing an equal number of aqueous compartments.

We know that nature is a wonderful and beautiful creation of God, which has bestowed upon us with many treasures including medicines. The history of diseases is as old as that of his existence on this planet and the search for remedies to combat them is also equally old.Liver diseases pose complications in treating them throughout the world since, conventional or synthetic drugs used in the treatment of liver diseases are few and with the risk of serious side effects. This is one of the reasons for many people all over the world including those in developed countries for turning towards complementary and alternative medicine. About 600 commercial preparations with claimed liver protecting activity are available all over the world. About 100 Indian medicinal plants belonging to 40 families are used for herbal formulation. In the present study Solanum melongena was selected for hepatoprotective activity study.

Typically in the pharmaceutical industry, drug products exist in two dosage forms, solid and liquid dosage forms. Included in solid dosage forms are tablets, pellets, pills, beads, spherules, etc. These solid dosage forms are often coated for various reasons, such as odor or taste masking, prevention from moisture, light and/or air, protection from destruction by gastric acid or gastric enzymes, enhanced mechanical strength, aesthetics or controlled release including controlling release sites and/or release rate.

It was first described by Alois Alzheimer in 1906. At a scientific meeting in November 1906, German physician Alois Alzheimer presented the case of "Frau Auguste D.," a 51-year-old woman brought to see him in 1901 by her family. Auguste had developed problems with memory, unfounded suspicions that her husband was unfaithful, and difficulty speaking and understanding what was said to her. Her symptoms rapidly grew worse, and within a few years she was bedridden. She died in spring 1906.Dr. Alzheimer had never before seen anyone like Auguste D., and he gained the family's permission to perform an autopsy. In Auguste's brain, he saw dramatic shrinkage, especially of the cortex, the outer layer involved in memory, thinking, judgment and speech. Under the microscope, he also saw widespread fatty deposits in small blood vessels, dead and dying brain cells, and abnormal deposits in and around cells. The condition entered the medical literature in 1907, when Alzheimer published his observations about Auguste D. In 1910, Emil Kraepelin, a psychiatrist noted for his work in naming and classifying brain disorders, proposed that the disease be named after Alzheimer.

Advancements of genomics, nanotechnology and biochemistry bring about new opportunities and challenges for drug discovery and development. Recent developments in nanotechnology have made it possible to obtain a new class of highly fluorescent homogeneous semiconductor nanocrystals termed "quantum dots''(QDs). Since 1998, quantum dots have been first demonstrated capable of labeling specific components of cells and tracing proteins within cells in biomedicine. Recently, the investigations of quantum dots in the biomedicine have developed rapidly. Quantum dots are very stable light emitters, and their emission can be broadly tuned through size variation. So they can offer significant advantages over organic fluorophores. In the past few years, it was reported that, as an alternative to organic fluorophores, bioconjugating quantum dots are used widely in diverse areas: cell labeling, cell tracking, in vivo imaging, DNA detection, biomacromolecules labeled, signal transduction and multiplexed beads encoded."

What does race have to do with religion? According to Khyati Y. Joshi, quite a bit. In this compelling look at the ways that second generation Indian Americans develop and change their sense of ethnic identity, she reveals how race and religion interact, intersect, and affect each other in a myriad of complex ways. In a society where Christianity and whiteness are the norm, most Indian Americans are both racial and religious minorities. At the same time - perceived as neither black nor white - they are a racially ambiguous population. One result of these factors is the racialization of religion, on which Joshi offers important insights in the wake of 9/11 and the intensified backlash against Americans who look Middle Eastern and South Asian. Drawing on case studies and in-depth interviews with forty-one second-generation Indian Americans, Joshi analyzes their experiences involving religion, race, and ethnicity from elementary school to adulthood. She shows how their identity has developed differently from their parents' and their non-Indian peers', and how religion often exerted a dramatic effect. She maps the many crossroads that they encounter as they navigate between home and religious community, family obligations and school, and a hope to retain their ethnic identity, while also feeling disconnected from their parents' generation. Through her candid insights into the internal conflicts that contemporary Indian Americans face as they negotiate this pastiche of experiences, and the religious and racial discrimination they encounter, Joshi provides a timely window into the ways that race, religion, and ethnicity coincide in day-to-day life.